<i>C. elegans</i> (VIDEO) University of Texas at Austin This video is under embargo. Please login to access this video. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Caption Texas Engineers have developed the first large-scale in vivo drug discovery platform using C. elegans -- a transparent roundworm that is used in the study of neurodegenerative diseases, including Parkinson's, Huntington's and Alzheimer's. Credit Cockrell School of Engineering Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.